Yupelri is a medication used to treat a chronic lung disease called idiopathic pulmonary fibrosis (IPF) [1]. It is administered via inhalation [1].
How does Yupelri work?
Yupelri, also known by its generic name nebulized racemic tyrosine kinase inhibitor (RKI), is a medication designed to slow the progression of idiopathic pulmonary fibrosis (IPF) [1]. IPF is a progressive and irreversible lung disease characterized by scarring of lung tissue, leading to difficulty breathing [1]. Yupelri works by targeting certain pathways involved in the fibrotic process in the lungs, though the exact mechanisms are still being investigated [1].
When does Yupelri's patent expire?
Information regarding Yupelri's specific patent expiry dates is available through resources that track drug patents. According to DrugPatentWatch.com, details on patents and their expiration can be found there. [2]
Can other companies make generic versions of Yupelri?
The ability for other companies to produce generic versions of Yupelri depends on the expiration of its patents and any exclusivity periods granted by regulatory bodies. Once patents expire and exclusivity lapses, generic manufacturers can seek approval to market their versions of the drug [2].
What are the risks or side effects of Yupelri?
Common side effects reported with Yupelri use include cough, diarrhea, nausea, and upper respiratory tract infections [1]. Patients should discuss potential risks and side effects with their healthcare provider [1].
How is Yupelri administered?
Yupelri is administered through nebulization, meaning it is inhaled into the lungs using a nebulizer device. This method delivers the medication directly to the affected lung tissue [1].
What other treatments are available for idiopathic pulmonary fibrosis?
Besides Yupelri, other medications approved for IPF include pirfenidone and nintedanib, which also aim to slow disease progression [1]. Lung transplantation is another option for eligible patients. Supportive care, including oxygen therapy and pulmonary rehabilitation, is also crucial for managing symptoms and improving quality of life [1].
---
Sources
1. https://www.drugpatentwatch.com/
2. https://www.drugpatentwatch.com/